402 related articles for article (PubMed ID: 35563604)
21. Metabolomics Biomarkers for Precision Psychiatry.
Shih PB
Adv Exp Med Biol; 2019; 1161():101-113. PubMed ID: 31562625
[TBL] [Abstract][Full Text] [Related]
22. Individualized metabolomics: opportunities and challenges.
Misra B
Clin Chem Lab Med; 2020 Jun; 58(6):939-947. PubMed ID: 30951498
[TBL] [Abstract][Full Text] [Related]
23. Recent and potential developments of biofluid analyses in metabolomics.
Zhang A; Sun H; Wang P; Han Y; Wang X
J Proteomics; 2012 Feb; 75(4):1079-88. PubMed ID: 22079244
[TBL] [Abstract][Full Text] [Related]
24. Plasma metabolomic profiles enhance precision medicine for volunteers of normal health.
Guo L; Milburn MV; Ryals JA; Lonergan SC; Mitchell MW; Wulff JE; Alexander DC; Evans AM; Bridgewater B; Miller L; Gonzalez-Garay ML; Caskey CT
Proc Natl Acad Sci U S A; 2015 Sep; 112(35):E4901-10. PubMed ID: 26283345
[TBL] [Abstract][Full Text] [Related]
25. Metabolomics and Personalized Medicine.
Koen N; Du Preez I; Loots du T
Adv Protein Chem Struct Biol; 2016; 102():53-78. PubMed ID: 26827602
[TBL] [Abstract][Full Text] [Related]
26. Integration of clinical phenoms and metabolomics facilitates precision medicine for lung cancer.
Yan F; Liu C; Song D; Zeng Y; Zhan Y; Zhuang X; Qiao T; Wu D; Cheng Y; Chen H
Cell Biol Toxicol; 2024 May; 40(1):25. PubMed ID: 38691184
[TBL] [Abstract][Full Text] [Related]
27. Multiomics Data Triangulation for Asthma Candidate Biomarkers and Precision Medicine.
Pecak M; Korošec P; Kunej T
OMICS; 2018 Jun; 22(6):392-409. PubMed ID: 29927718
[TBL] [Abstract][Full Text] [Related]
28. Omics sciences and precision medicine in lung cancer.
Micheletti C; Dhuli K; Donato K; Gadler M; Benedetti S; Guerri G; Cristofoli F; Generali D; Donofrio CA; Cominetti M; Fioravanti A; Riccio L; Bernini A; Fulcheri E; Stuppia L; Stuppia L; Gatta V; Cristoni S; Cecchin S; Marceddu G; Bertelli M
Clin Ter; 2023; 174(Suppl 2(6)):37-45. PubMed ID: 37994747
[TBL] [Abstract][Full Text] [Related]
29. Challenges and opportunities of metabolomics.
Johnson CH; Gonzalez FJ
J Cell Physiol; 2012 Aug; 227(8):2975-81. PubMed ID: 22034100
[TBL] [Abstract][Full Text] [Related]
30. Metabolomics as a Truly Translational Tool for Precision Medicine.
Schmidt JC; Dougherty BV; Beger RD; Jones DP; Schmidt MA; Mattes WB
Int J Toxicol; 2021 Oct; 40(5):413-426. PubMed ID: 34514887
[TBL] [Abstract][Full Text] [Related]
31. Metabolomics Applications in Precision Medicine: An Oncological Perspective.
Puchades-Carrasco L; Pineda-Lucena A
Curr Top Med Chem; 2017; 17(24):2740-2751. PubMed ID: 28685691
[TBL] [Abstract][Full Text] [Related]
32. Multi-omics approaches for precision obesity management : Potentials and limitations of omics in precision prevention, treatment and risk reduction of obesity.
Woldemariam S; Dorner TE; Wiesinger T; Stein KV
Wien Klin Wochenschr; 2023 Mar; 135(5-6):113-124. PubMed ID: 36717394
[TBL] [Abstract][Full Text] [Related]
33. STRATEGIES AND CHALLENGES IN METHOD DEVELOPMENT AND VALIDATION FOR THE ABSOLUTE QUANTIFICATION OF ENDOGENOUS BIOMARKER METABOLITES USING LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY.
Khamis MM; Adamko DJ; El-Aneed A
Mass Spectrom Rev; 2021 Jan; 40(1):31-52. PubMed ID: 31617245
[TBL] [Abstract][Full Text] [Related]
34. Precision of a Clinical Metabolomics Profiling Platform for Use in the Identification of Inborn Errors of Metabolism.
Ford L; Kennedy AD; Goodman KD; Pappan KL; Evans AM; Miller LAD; Wulff JE; Wiggs BR; Lennon JJ; Elsea S; Toal DR
J Appl Lab Med; 2020 Mar; 5(2):342-356. PubMed ID: 32445384
[TBL] [Abstract][Full Text] [Related]
35. Omics for the future in asthma.
Abdel-Aziz MI; Neerincx AH; Vijverberg SJ; Kraneveld AD; Maitland-van der Zee AH
Semin Immunopathol; 2020 Feb; 42(1):111-126. PubMed ID: 31942640
[TBL] [Abstract][Full Text] [Related]
36. Omics-Based Strategies in Precision Medicine: Toward a Paradigm Shift in Inborn Errors of Metabolism Investigations.
Tebani A; Afonso C; Marret S; Bekri S
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27649151
[TBL] [Abstract][Full Text] [Related]
37. Exploration of variations in proteome and metabolome for predictive diagnostics and personalized treatment algorithms: Innovative approach and examples for potential clinical application.
Zhan X; Long Y; Lu M
J Proteomics; 2018 Sep; 188():30-40. PubMed ID: 28851587
[TBL] [Abstract][Full Text] [Related]
38. Metabolomics: Applications and Promise in Mycobacterial Disease.
Mirsaeidi M; Banoei MM; Winston BW; Schraufnagel DE
Ann Am Thorac Soc; 2015 Sep; 12(9):1278-87. PubMed ID: 26196272
[TBL] [Abstract][Full Text] [Related]
39. The metabolomics side of frailty: Toward personalized medicine for the aged.
Picca A; Coelho-Junior HJ; Cesari M; Marini F; Miccheli A; Gervasoni J; Bossola M; Landi F; Bernabei R; Marzetti E; Calvani R
Exp Gerontol; 2019 Oct; 126():110692. PubMed ID: 31421185
[TBL] [Abstract][Full Text] [Related]
40. Integrating clinical metabolomics-based biomarker discovery and clinical pharmacology to enable precision medicine.
Kohler I; Hankemeier T; van der Graaf PH; Knibbe CAJ; van Hasselt JGC
Eur J Pharm Sci; 2017 Nov; 109S():S15-S21. PubMed ID: 28502671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
